Market Overview

Why Moderna's Stock Is Trading Higher Today

Why Moderna's Stock Is Trading Higher Today

Moderna (NASDAQ: MRNA) shares are trading higher on Thursday amid growing concerns of U.S. coronavirus cases. Dr. Anthony Fauci earlier said the company will likely be going into advanced Phase 3 trials by the end of July.

Moderna is engaged in creating transformative medicines based on messenger RNA, or mRNA. It transfers the information stored in the genes to the cellular machinery that makes all the proteins required for life. The firm is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases.

Moderna shares were trading up 5.17% at $64.76 at the time of publication on Thursday. The stock has a 52-week high of $87 and a 52-week low of $11.54.

See Also:

Moderna Strikes Another Coronavirus Vaccine Manufacturing Deal To Ensure Overseas Supply


Related Articles (MRNA)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Health Care General